Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the National Cancer Institute

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/DJG058PMID 14519750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis

  2020cited by this paper
• A phase II study of cisplatin, 5 fluorouracil (5-FU), radiation (RT) and celecoxib in patients with resectable esophageal cancer (EC): Updated results from the Hoosier Oncology Group (HOG) study

  2004cited by this paper
• Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line

  2004cited by this paper
• Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

  2002cited by this paper
• Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

  2002cited by this paper
• Increased expression of cyclooxygenase‐2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

  2002cited by this paper
• Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

  2002cited by this paper
• Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance

  2002cited by this paper
• Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

  2002cited by this paper
• Cyclooxygenase‐2 expression in endometrial carcinoma

  2002cited by this paper
• Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in bronchial epithelium and nonsmall cell lung carcinoma

  2002cited by this paper
• In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.

  2002cited by this paper
• p53‐mediated induction of Cox‐2 counteracts p53‐ or genotoxic stress‐induced apoptosis

  2002cited by this paper
• Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.

  2002cited by this paper
• Immunohistochemical analysis and in situ hybridization of cyclooxygenase‐2 expression in intraductal papillary‐mucinous tumors of the pancreas

  2002cited by this paper
• Celecoxib: a specific COX-2 inhibitor with anticancer properties.

  2002cited by this paper
• The Antiangiogenic Agents SU5416 and SU6668 Increase the Antitumor Effects of Fractionated Irradiation

  2002cited by this paper
• Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.

  2002cited by this paper
• Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.

  2002cited by this paper
• Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

  2002cited by this paper
• Apoptosis induced by low‐dose and low‐dose‐rate radiation

  2002cited by this paper
• Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors.

  2001cited by this paper
• Expression of Inflammatory Modulator COX-2 in Pancreatic Ductal Adenocarcinoma and Its Relationship to Pathologic and Clinical Parameters

  2001cited by this paper
• Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

  2001cited by this paper
• Cyclooxygenase-2 is overexpressed in human cervical cancer.

  2001cited by this paper
• Characterization of the Effects of Antiangiogenic Agents on Tumor Pathophysiology

  2001cited by this paper
• Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

  2001cited by this paper
• Expression of cyclooxygenase 2 in human malignant melanoma.

  2001cited by this paper
• Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.

  2001cited by this paper
• Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

  2001cited by this paper
• Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth

  2001cited by this paper
• Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.

  2001cited by this paper
• Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms.

  2001cited by this paper
• Increased expression of cyclooxygenase‐2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

  2001cited by this paper
• Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

  2001cited by this paper
• Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.

  2001cited by this paper
• Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

  2001cited by this paper
• A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

  2001cited by this paper
• American Society for Therapeutic Radiology and Oncology

  2001cited by this paper
• Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.

  2001cited by this paper
• Cyclooxygenase-2 expression in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence

  2001cited by this paper
• The role of cyclooxygenase-2 in prostate cancer.

  2001cited by this paper
• Cyclooxygenase inhibitors--current status and future prospects.

  2001cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.

  2001cited by this paper
• Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.

  2001cited by this paper
• Elevated COX-2 Expression in Cervical Carcinoma: Reduced Cause-Specific Survival and Pelvic Control

  2001cited by this paper
• COX‐2 and cancer: a new approach to an old problem

  2001cited by this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001cited by this paper
• Expression of cyclooxygenase‐2 in human gastric adenomas and adenocarcinomas

  2001cited by this paper
• EXPRESSION OF CYCLOOXYGENASE‐1 AND‐2 IN URINARY BLADDER CARCINOMAS IN VIVO AND IN VITRO AND PROSTAGLANDIN E 2 SYNTHESIS IN CULTURED BLADDER CANCER CELLS

  2001cited by this paper
• Biological Basis of Radiation Sensitivity

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.

  2000cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.

  2000cited by this paper
• Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1

  2000cited by this paper
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

  2000cited by this paper
• Cyclooxygenase mechanisms.

  2000cited by this paper
• Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.

  2000cited by this paper
• High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.

  2000cited by this paper
• Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury.

  2000cited by this paper
• Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

  2000cited by this paper
• Biological basis of radiation sensitivity. Part 1: Factors governing radiation tolerance.

  2000cited by this paper
• Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism.

  2000cited by this paper
• Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Association of Preoperative Radiation Effect with Tumor Angiogenesis and Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma

  2000cited by this paper
• Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.

  2000cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

  2000cited by this paper
• Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

  2000cited by this paper
• Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.

  2000cited by this paper
• Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

  2000cited by this paper
• Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells.

  2000cited by this paper
• Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.

  1999cited by this paper
• Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

  1999cited by this paper
• An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

  1999cited by this paper
• Cyclooxygenase-2 expression in human esophageal carcinoma.

  1999cited by this paper
• Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

  1999cited by this paper
• Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors

  1999cited by this paper
• Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation

  1999cited by this paper
• Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

  1999cited by this paper
• Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.

  1999cited by this paper
• Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

  1999cited by this paper
• Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma

  1999cited by this paper
• Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

  1999cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999cited by this paper
• Cyclooxygenase-2 expression in hepatocellular carcinoma.

  1999cited by this paper
• Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

  1999cited by this paper
• The relationship between cyclooxygenase-2 expression and colorectal cancer.

  1999cited by this paper
• Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

  1999cited by this paper
• Molecular regulation of UVB-induced cutaneous angiogenesis.

  1998cited by this paper
• Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

  1998cited by this paper
• Combined effects of angiostatin and ionizing radiation in antitumour therapy

  1998cited by this paper
• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  1998cited by this paper

• Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer

  2025cites this paper
• Effect of Chemotherapy on Vascularization of Cervical Cancer

  2025cites this paper
• Efficacy and safety of low-dose celecoxib with chemoradiation in locally advanced head-and-neck squamous cell carcinoma

  2024cites this paper
• Repurposing radiosensitising medicines for radiotherapy: an overview

  2024cites this paper
• In defense of platinum: Amino acidic polydentate ligands as a shield against sulphur-donor nucleophilic attacks

  2024cites this paper
• Early and long-term responses of intestinal microbiota and metabolites to 131I treatment in differentiated thyroid cancer patients

  2024cites this paper
• Etoricoxib nanostructured lipid carriers attenuate inflammation by modulating Cyclooxygenase-2 signaling and activation of nuclear factor-κB-p65 pathways in radiation-induced acute cardiotoxicity in rats.

  2023cites this paper
• Amino Acids as Chelating Ligands for Platinum: Enhanced Stability in an Aqueous Environment Promoted by Biocompatible Molecules

  2023cites this paper
• Meloxicam can Potentiate the Therapeutic Effects of Synchrotron Microbeam Radiation Therapy on High-Grade Glioma Bearing Rats

  2022influential citation
• Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer

  2022cites this paper
• New thiophene derivative augments the antitumor activity of γ-irradiation against colorectal cancer in mice via anti-inflammatory and pro-apoptotic pathways

  2022cites this paper
• The Efficacy of Celecoxib during Chemoradiation in Locally Advanced Head and Neck Carcinoma; A Phase 2 Randomized Placebo Control Clinical Trial

  2021cites this paper
• Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy

  2021cites this paper
• Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study

  2021cites this paper
• A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy

  2021cites this paper
• The multiple effects of aspirin in prostate cancer patients.

  2020cites this paper
• Radiation mitigating activities of Psidium guajava L. against whole-body X-ray-induced damages in albino Wistar rat model

  2020cites this paper
• Targets for protection and mitigation of radiation injury

  2020cites this paper
• Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance

  2020cites this paper
• C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression

  2019cites this paper
• Targets for improving tumor response to radiotherapy.

  2019cites this paper
• Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background

  2019cites this paper
• Addition of Etoricoxib During Concurrent Chemo-radiation of Cervical Cancer Patients Could Result in Faster Resolution of Gross Disease: A Prospective Single-Institution Study

  2019cites this paper
• Cyclooxygenase-2-Mediated Up-Regulation of Mitochondrial Transcription Factor A Mitigates the Radio-Sensitivity of Cancer Cells

  2019cites this paper
• COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models.

  2018cites this paper
• Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy

  2018cites this paper
• Nitric Oxide-Releasing Selective Cyclooxygenase-2 Inhibitors as Promising Radiosensitizers in Melanoma Cells In Vitro

  2018cites this paper
• Presence and Quantity of COX-2 in Lymph Node Metastases of Patients with Head and Neck Cancer

  2017cites this paper
• Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer

  2017cites this paper
• Hubungan ekspresi cyclooxygenase-2 (cox-2) dengan stadium klinis pada karsinoma nasofaring tipe undifferentiated carcinoma

  2017cites this paper
• Enhancement of Bleomycin Sensitivity in Human Lung Cancer Cell Line using Centella asiatica Leaf Extract

  2016cites this paper
• Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cells

  2016cites this paper
• Cyclooxygenase 1 (COX1) expression in Type 2 diabetes mellitus: A preliminary study from north India

  2016cites this paper
• Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer

  2016cites this paper
• Therapeutic Strategies, the Concept of “Normalization” and the Role of VEGF Inhibition

  2016cites this paper
• Cyclooxygenase 1 ( COX 1 ) expression in Type 2 diabetes mellitus : A preliminary study from north India

  2016cites this paper
• Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review

  2016cites this paper
• Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy

  2015cites this paper
• The role of celecoxib as a COX-2 inhibitor increasing the radiosensitivity of tumor tissue.

  2015cites this paper
• G-protein coupled receptor expression in medulloblastoma subgroups: Identifying and exploiting molecular targets

  2015cites this paper
• Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.

  2015cites this paper
• Efficacy and vitreous levels of topical NSAIDs

  2015cites this paper
• Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity

  2015cites this paper
• The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker

  2015cites this paper
• Cytosolic Phospholipase A2 and Autotaxin Inhibitors as Potential Radiosensitizers

  2014cites this paper
• Laporan Penelitian Korelasi positif ekspresi cyclooxygenase-2 dengan microvessel density pada karsinoma nasofaring

  2014cites this paper
• Angiogenesis in tumor and adjacent non - tumorous parenchyma - molecular presentation before and after therapy

  2014cites this paper
• Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer

  2014cites this paper
• Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.

  2014cites this paper
• Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention

  2014cites this paper
• Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy.

  2014cites this paper
• 10 New Therapeutic Targets

  2014cites this paper
• COX-2 signaling and cancer: new players in old arena.

  2014cites this paper
• Clinical Response in Nasopharyngeal Carcinoma with Combined Therapy of Concurrent Chemoradiotherapy and NSAIDs: Etoricoxib vs Piroxicam

  2014influential citation
• Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.

  2013cites this paper
• Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial.

  2013cites this paper
• Nuclear EGFR as a molecular target in cancer.

  2013cites this paper
• G-protein coupled receptor expression patterns delineate medulloblastoma subgroups

  2013cites this paper
• Therapeutic response to a new enzyme-targeting radiosensitization treatment (KORTUC-SC) for patients with chemotherapy-resistant supraclavicular lymph node metastasis

  2013cites this paper
• Radiosensitization in prostate cancer: mechanisms and targets

  2013cites this paper
• neovascularization induced by growth factors and human tumor cells Proangiogenic role of neutrophil-like inflammatory heterophils during

  2013cites this paper
• Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

  2013influential citation
• In vitro cytotoxic evaluation of some synthesized COX-2 inhibitor derivatives against a panel of human cancer cell lines

  2013cites this paper
• COX-2 in cancer: Gordian knot or Achilles heel?

  2013cites this paper
• Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

  2012cites this paper
• Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells

  2012cites this paper
• Análise do papel da prostaglandina E2 e seus receptores na proliferação e apoptose em glioma humano, e da expressão das enzimas COX-1, COX-2, mPGES-1, mPGES-2 e cPGES

  2012cites this paper
• Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.

  2012cites this paper
• New Therapeutic Targets

  2012cites this paper
• Nitroxide derivatives of non‐steroidal anti‐inflammatory drugs exert anti‐inflammatory and superoxide dismutase scavenging properties in A459 cells

  2012influential citation
• Predictors of Cervical Cancer Screening: An Application of Health Belief Model

  2012cites this paper
• Topics on Cervical Cancer With an Advocacy for Prevention

  2012cites this paper
• Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis

  2012cites this paper
• The role of inflammation induced by radiation or lipopolysaccharides in the metastatic process in a mouse model of breast cancer

  2012cites this paper
• Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.

  2011cites this paper
• Psoralidin, a dual inhibitor of COX‐2 and 5‐LOX, regulates ionizing radiation (IR)‐induced pulmonary inflammation

  2011cites this paper
• Role of TLR2‐dependent inflammation in metastatic progression

  2011cites this paper
• Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.

  2011cites this paper
• Evaluation of the Antitumor and Radiosynthetizing Activity of a Novel Quinoline Sulfonamide Derivative (PIQSA) as a Histone Deacetylase Inhibitor

  2011cites this paper
• Cyclooxygenase-2 in oncogenesis.

  2011cites this paper
• Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: a phase II-III clinical trial.

  2011cites this paper
• Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.

  2011cites this paper
• Observation of Curative Efficacy and Prognosis following Combination Chemotherapy with Celecoxib in the Treatment of Advanced Colorectal Cancer

  2011cites this paper
• Radioprotectors and Chemoprotectors in the Management of Lung Cancer

  2011cites this paper
• Are cancer stem cells radioresistant?

  2010cites this paper
• New potential targets in medulloblastoma therapy : Studies on cellular mechanisms and mediators

  2010cites this paper
• Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.

  2010cites this paper
• Exploiting cyclooxygenase-(in)dependent properties of COX-2 inhibitors for malignant glioma therapy.

  2010cites this paper
• The Metabolic Achilles Heel: Tumor Cell Metabolism as Therapeutic Target

  2010cites this paper
• NEOADJUVANT CHEMO RADIATION WITH CAPCITABINE AND CELECOXIB IN STAGE II AND III RECTAL ADENOCARCINOMA

  2010cites this paper
• Identification of differentially expressed genes related to radioresistance of human esophageal cancer cells.

  2010cites this paper
• CORRELATION BETWEEN COX-2 EXPRESSION WITH HISTOPATHOLOGICAL GRADING IN ASTROCYTOMA

  2010cites this paper
• Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.

  2010cites this paper
• Effects of irradiation on tumor cell survival, invasion and angiogenesis

  2010cites this paper
• COX-2 Inhibitors Are Contraindicated for Treatment of Combined Injury

  2009cites this paper
• When neighbourhood matters: tumour microenvironment

  2009cites this paper
• Molecular fingerprinting of radiation resistant tumors: Can we apprehend and rehabilitate the suspects?

  2009cites this paper
• La signification pronostique de l'expression de la cyclooxygénase 2 dans le cancer du larynx glottique de stade précoce traité par radiothérapie

  2009influential citation
• Expression of the CD117, COX-2 and HSP90 antigens and cell proliferation in fine-needle-aspirated cells from metastatic melanomas.

  2009cites this paper
• Effects of AT1R antagonist L-158,809 on normal brain tissue injury following whole -brain irradiation

  2009cites this paper